301 related articles for article (PubMed ID: 31069536)
1. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-Acanthamoeba synergistic effect of chlorhexidine and cationic carbosilane dendrimers against both trophozoite and cyst forms.
Heredero-Bermejo I; Sánchez-Nieves J; Soliveri J; Gómez R; de la Mata FJ; Copa-Patiño JL; Pérez-Serrano J
Int J Pharm; 2016 Jul; 509(1-2):1-7. PubMed ID: 27173821
[TBL] [Abstract][Full Text] [Related]
3. Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts.
López-Barona P; Verdú-Expósito C; Martín-Pérez T; Gómez-Casanova N; Lozano-Cruz T; Ortega P; Gómez R; Pérez-Serrano J; Heredero-Bermejo I
Sci Rep; 2022 Sep; 12(1):14926. PubMed ID: 36056060
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.
Heredero-Bermejo I; Copa-Patiño JL; Soliveri J; Fuentes-Paniagua E; de la Mata FJ; Gomez R; Perez-Serrano J
Parasitol Res; 2015 Feb; 114(2):473-86. PubMed ID: 25358240
[TBL] [Abstract][Full Text] [Related]
5. Effects of polyhexamethylene biguanide and chlorhexidine on four species of Acanthamoeba in vitro.
Tirado-Angel J; Gabriel MM; Wilson LA; Ahearn DG
Curr Eye Res; 1996 Feb; 15(2):225-8. PubMed ID: 8670733
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis affects biguanide sensitivity of Acanthamoeba spp.
Noble JA; Ahearn DG; Avery SV; Crow SA
Antimicrob Agents Chemother; 2002 Jul; 46(7):2069-76. PubMed ID: 12069957
[TBL] [Abstract][Full Text] [Related]
7. Effects of lactoferrin on the viability and the encystment of Acanthamoeba trophozoites.
Tomita S; Suzuki C; Wada H; Nomachi M; Imayasu M; Araki-Sasaki K
Biochem Cell Biol; 2017 Feb; 95(1):48-52. PubMed ID: 28140621
[TBL] [Abstract][Full Text] [Related]
8. Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii.
Moon EK; Choi HS; Kong HH; Quan FS
Exp Parasitol; 2018 Aug; 191():31-35. PubMed ID: 29885293
[TBL] [Abstract][Full Text] [Related]
9. Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.
Alizadeh H; Neelam S; Cavanagh HD
Eye Contact Lens; 2009 Jan; 35(1):1-5. PubMed ID: 19125040
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Sharma G; Kalra SK; Tejan N; Ghoshal U
Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
[TBL] [Abstract][Full Text] [Related]
11. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
12. Development of standardized methods for assessing biocidal efficacy of contact lens care solutions against Acanthamoeba trophozoites and cysts.
Kilvington S; Lam A
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4527-37. PubMed ID: 23745008
[TBL] [Abstract][Full Text] [Related]
13. Resistance, biguanide sorption and biguanide-induced pentose leakage during encystment of Acanthamoeba castellanii.
Turner NA; Russell AD; Furr JR; Lloyd D
J Appl Microbiol; 2004; 96(6):1287-95. PubMed ID: 15139921
[TBL] [Abstract][Full Text] [Related]
14. Development of a new oxygen consumption rate assay in cultures of Acanthamoeba (Protozoa: Lobosea) and its application to evaluate viability and amoebicidal activity in vitro.
Heredero-Bermejo I; Criado-Fornelio A; Soliveri J; Díaz-Martín JA; Matilla-Fuentes J; Sánchez-Arias JA; Copa-Patiño JL; Pérez-Serrano J
Exp Parasitol; 2015 Aug; 155():35-9. PubMed ID: 25956947
[TBL] [Abstract][Full Text] [Related]
15. Dual 0.02% chlorhexidine digluconate - 0.1% disodium EDTA loaded thermosensitive ocular gel for Acanthamoeba keratitis treatment.
Cucina A; Filali S; Risler A; Febvay C; Salmon D; Pivot C; Pelandakis M; Pirot F
Int J Pharm; 2019 Feb; 556():330-337. PubMed ID: 30553004
[TBL] [Abstract][Full Text] [Related]
16. Protamine as a potential amoebicidal agent for contact lens disinfection.
Vijay AK; Bandara M; Zhu H; Willcox MD
Optom Vis Sci; 2013 Feb; 90(2):119-24. PubMed ID: 23334310
[TBL] [Abstract][Full Text] [Related]
17. Contact lens care solution killing efficacy against Acanthamoeba castellanii by in vitro testing and live-imaging.
Kolar SS; Manarang JC; Burns AR; Miller WL; McDermott AM; Bergmanson JP
Cont Lens Anterior Eye; 2015 Dec; 38(6):442-50. PubMed ID: 26208952
[TBL] [Abstract][Full Text] [Related]
18. Optimized Protocol for Testing Multipurpose Contact Lens Solution Efficacy Against Acanthamoeba.
Fedorko DP; Brocious JM; Adams KD; Hitchins VM; Hampton DL; Eydelman MB
Eye Contact Lens; 2018 Nov; 44(6):367-371. PubMed ID: 29373390
[TBL] [Abstract][Full Text] [Related]
19. Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.
Johnston SP; Sriram R; Qvarnstrom Y; Roy S; Verani J; Yoder J; Lorick S; Roberts J; Beach MJ; Visvesvara G
J Clin Microbiol; 2009 Jul; 47(7):2040-5. PubMed ID: 19403771
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
